- Home
- NVFY vs SYBX Comparison
NVFY vs SYBX Comparison
Compare NVFY & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- SYBX
- Stock Information
- Founded
- NVFY 2003
- SYBX N/A
- Country
- NVFY United States
- SYBX United States
- Employees
- NVFY N/A
- SYBX N/A
- Industry
- NVFY Home Furnishings
- SYBX Biotechnology: Pharmaceutical Preparations
- Sector
- NVFY Consumer Discretionary
- SYBX Health Care
- Exchange
- NVFY Nasdaq
- SYBX Nasdaq
- Market Cap
- NVFY 14.3M
- SYBX 13.6M
- IPO Year
- NVFY N/A
- SYBX N/A
- Fundamental
- Price
- NVFY $1.34
- SYBX $1.26
- Analyst Decision
- NVFY
- SYBX
- Analyst Count
- NVFY 0
- SYBX 0
- Target Price
- NVFY N/A
- SYBX N/A
- AVG Volume (30 Days)
- NVFY 83.4K
- SYBX 7.8K
- Earning Date
- NVFY 08-13-2025
- SYBX 08-07-2025
- Dividend Yield
- NVFY N/A
- SYBX N/A
- EPS Growth
- NVFY N/A
- SYBX N/A
- EPS
- NVFY N/A
- SYBX 0.21
- Revenue
- NVFY $9,946,300.00
- SYBX N/A
- Revenue This Year
- NVFY N/A
- SYBX N/A
- Revenue Next Year
- NVFY N/A
- SYBX N/A
- P/E Ratio
- NVFY N/A
- SYBX $5.82
- Revenue Growth
- NVFY N/A
- SYBX N/A
- 52 Week Low
- NVFY $0.39
- SYBX $0.90
- 52 Week High
- NVFY $2.08
- SYBX $1.88
- Technical
- Relative Strength Index (RSI)
- NVFY 57.30
- SYBX 52.81
- Support Level
- NVFY $1.27
- SYBX $1.17
- Resistance Level
- NVFY $1.51
- SYBX $1.27
- Average True Range (ATR)
- NVFY 0.30
- SYBX 0.04
- MACD
- NVFY 0.00
- SYBX -0.01
- Stochastic Oscillator
- NVFY 42.72
- SYBX 40.00
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.